-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ROfp2CuPsimSX2yg4urJJ/1VQa8uuSV96LFeK2Usyl6CZOFpq8wAUzLNzC0dZVTS jmi54vU/fmI4Zx8s4i4S4A== 0001144204-08-033260.txt : 20080602 0001144204-08-033260.hdr.sgml : 20080602 20080602174112 ACCESSION NUMBER: 0001144204-08-033260 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080528 FILED AS OF DATE: 20080602 DATE AS OF CHANGE: 20080602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neuralstem, Inc. CENTRAL INDEX KEY: 0001357459 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 522007292 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9700 GREAT SENECA HIGHWAY CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 3013664841 MAIL ADDRESS: STREET 1: 9700 GREAT SENECA HIGHWAY CITY: ROCKVILLE STATE: MD ZIP: 20850 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OLDAKER WILLIAM CLYDE CENTRAL INDEX KEY: 0001397571 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33672 FILM NUMBER: 08875026 BUSINESS ADDRESS: BUSINESS PHONE: 202 728 1010 MAIL ADDRESS: STREET 1: 818 CONNECTICUT AVENUE NW STREET 2: SUITE 1100 CITY: WASHINGTON STATE: DC ZIP: 20006 4 1 v116314_ex.xml X0202 4 2008-05-28 0 0001357459 Neuralstem, Inc. CUR 0001397571 OLDAKER WILLIAM CLYDE 818 CONNECTICUT AVENUE NW SUITE 1100 WASHINGTON DC 20006 1 0 0 0 Common Stock 2008-05-30 4 P 0 10000 1.60 A 48200 D 60,000 1.32 2008-05-28 4 A 0 60000 A 2015-05-28 Common Stock 60000 155000 D Options granted pursuant to Issuer's 2007 Stock Plan and in compliance with its non-executive director compensation plan. The grant consists of: (i) 45,000 options as compensation for serving on the board of directors; (ii) 5,000 options as compensation for serving on the Issuer's Audit Committee, (iii) 5,000 options as compensation for serving on the Issuer's Compensation Committee; and (iv) 5,000 options as compensation for serving on the Issuer's Governance and Nominating Committee. The options vest quarterly over the grant year and expire 7 years from the date of grant. /s/ William Oldaker 2008-06-02 -----END PRIVACY-ENHANCED MESSAGE-----